Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Heiner K. Berthold, Kaspar Berneis, Christos S. Mantzoros, Wilhelm Krone & Ioanna Gouni-Berthold. (2013) Effects of simvastatin and ezetimibe on interleukin-6 and high-sensitivity C-reactive protein. Scandinavian Cardiovascular Journal 47:1, pages 20-27.
Read now
Read now
Richard J. Willke, Steve Zhou & Robert A. Vogel. (2008) Differences in cardiovascular event rates between atorvastatin and simvastatin among new users: managed-care experience. Current Medical Research and Opinion 24:10, pages 2873-2882.
Read now
Read now
Harold Bays & Evan A Stein. (2003) Pharmacotherapy for dyslipidaemia – current therapies and future agents. Expert Opinion on Pharmacotherapy 4:11, pages 1901-1938.
Read now
Read now
Articles from other publishers (37)
Hongli Dong, Jie Wang, Ping Hu & Nan Lu. (2022) Association of Apolipoprotein A1, High Density Lipoprotein Cholesterol, and Their Ratio with Inflammatory Marker in Chinese Adults with Coronary Artery Disease. Angiology 74:8, pages 765-773.
Crossref
Crossref
. 2019. Cardiovascular Disease. Cardiovascular Disease
415
510
.
Scott Kinlay. (2011) Role of C-Reactive Protein When Prescribing a Statin. Current Atherosclerosis Reports 14:1, pages 26-32.
Crossref
Crossref
Cristine Skogastierna, Leonid Luksha, Karolina Kublickiene, Erik Eliasson, Anders Rane & Lena Ekström. (2011) Beneficial vasoactive endothelial effects of fluvastatin: focus on prostacyclin and nitric oxide. Heart and Vessels 26:6, pages 628-636.
Crossref
Crossref
M. Andrikoula & I. F. W. McDowell. (2008) The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment. Diabetes, Obesity and Metabolism 10:4, pages 271-278.
Crossref
Crossref
José Marín-García, Michael J. Goldenthal & Gordon W. Moe. 2008. Aging and the Heart. Aging and the Heart
239
276
.
Scott Kinlay. (2007) Low-Density Lipoprotein-Dependent and -Independent Effects of Cholesterol-Lowering Therapies on C-Reactive Protein. Journal of the American College of Cardiology 49:20, pages 2003-2009.
Crossref
Crossref
René Schramm, Michael D. Menger, Yves Harder, Rudolf Schmits, Oliver Adam, Gabriele Weitz-Schmidt & Hans-Joachim Schäfers. (2007) Statins inhibit lymphocyte homing to peripheral lymph nodes. Immunology 120:3, pages 315-324.
Crossref
Crossref
Li-Teh Chang, Cheuk-Kwan Sun, Chiang-Hua Chiang, Chiung-Jen Wu, Sarah Chua & Hon-Kan Yip. (2007) Impact of Simvastatin and Losartan on Antiinflammatory Effect: In Vitro Study. Journal of Cardiovascular Pharmacology 49:1, pages 20-26.
Crossref
Crossref
L.U. Zimmerli, P.B. Mark, T. Steedman, J.E. Foster, G.A. Berg, H.J. Dargie, A.G. Jardine, C. Delles & A.F. Dominiczak. (2007) Vascular function in patients with end-stage renal disease and/or coronary artery disease: A cardiac magnetic resonance imaging study. Kidney International 71:1, pages 68-73.
Crossref
Crossref
Stefan Störk, Richard A. Feelders, Annewieke W. van den Beld, Ewout W. Steyerberg, Huub F.J. Savelkoul, Steven W.J. Lamberts, Diederick E. Grobbee & Michiel L. Bots. (2006) Prediction of Mortality Risk in the Elderly. The American Journal of Medicine 119:6, pages 519-525.
Crossref
Crossref
J Sundell, H Laine, P Nuutila, M Luotolahti & J Knuuti. (2005) Short-term changes in inflammatory response protein (hsCRP) do not parallel with changes in coronary vasoreactivity in obese men. International Journal of Obesity 30:3, pages 460-467.
Crossref
Crossref
. 2005. Cardiovascular Disease. Cardiovascular Disease
312
370
.
Guixiang Zhao, Terry D. Etherton, Keith R. Martin, Sheila G. West, Peter J. Gillies & Penny M. Kris-Etherton. (2004) Dietary α-Linolenic Acid Reduces Inflammatory and Lipid Cardiovascular Risk Factors in Hypercholesterolemic Men and Women. The Journal of Nutrition 134:11, pages 2991-2997.
Crossref
Crossref
Won-Young Lee, Jung-Yul Suh, Eun-Jung Rhee, Jeong-Sik Park, Ki-Chul Sung & Sun-Woo Kim. (2004) Plasma CRP, apolipoprotein A-1, apolipoprotein B and Lp(a) levels according to thyroid function status. Archives of Medical Research 35:6, pages 540-545.
Crossref
Crossref
Kevin M. Douglas, Allen J. Taylor & Patrick G. O’Malley. (2004) Relationship Between Depression and C-Reactive Protein in a Screening Population. Psychosomatic Medicine 66:5, pages 679-683.
Crossref
Crossref
G. Walldius & I. Jungner. (2004) Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy. Journal of Internal Medicine 255:2, pages 188-205.
Crossref
Crossref
Sridevi Devaraj & Ishwarlal Jialal. 2004. Statins. Statins
189
201
.
Junji Kobayashi, Sumiko Tateishi, Tokiko Maruyama, Akito Kudoh & Shunichi Murano. (2003) Marked reduction in serum high-density lipoprotein cholesterol concentrations in a woman with acute inflammation due to diabetic gangrene. Clinica Chimica Acta 335:1-2, pages 33-38.
Crossref
Crossref
Winfried Marz & Wolfgang Koenig. (2003) Journal of Cardiovascular Risk 10:3, pages 169-179.
Crossref
Crossref
Mira Choi, Susanne Rolle, Madhavi Rane, Hermann Haller, Friedrich C. Luft & Ralph Kettritz. (2003) Extracellular signal-regulated kinase inhibition by statins inhibits neutrophil activation by ANCA. Kidney International 63:1, pages 96-106.
Crossref
Crossref
M.A van de Ree, M.V Huisman, H.M.G Princen, A.E Meinders & C Kluft. (2003) Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus. Atherosclerosis 166:1, pages 129-135.
Crossref
Crossref
A Sierksma, MS van der Gaag, C Kluft & HFJ Hendriks. (2002) Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomized, diet-controlled intervention study. European Journal of Clinical Nutrition 56:11, pages 1130-1136.
Crossref
Crossref
Hiroki Teragawa, Yukihiro Fukuda, Keiji Matsuda, Yukihito Higashi, Togo Yamagata, Hideo Matsuura & Kazuaki Chayama. (2002) Effect of alcohol consumption on endothelial function in men with coronary artery disease. Atherosclerosis 165:1, pages 145-152.
Crossref
Crossref
Harold E Bays, Evan A Stein, Arvind K Shah, Darbie L Maccubbin, Yale B Mitchel & Michele Mercuri. (2002) Effects of simvastatin on C-reactive protein in mixed hyperlipidemic and hypertriglyceridemic patients. The American Journal of Cardiology 90:9, pages 942-946.
Crossref
Crossref
Tor M Lund, Harald Torsvik, Dagfinn Falch, B.jørn Christophersen, Rita Skårdal & Lars Gullestad. (2002) Effect of morning versus evening intake of simvastatin on the serum cholesterol level in patients with coronary artery disease. The American Journal of Cardiology 90:7, pages 784-786.
Crossref
Crossref
Paresh Dandona & Ahmad Aljada. (2002) A rational approach to pathogenesis and treatment of type 2 diabetes mellitus, insulin resistance, inflammation, and atherosclerosis. The American Journal of Cardiology 90:5, pages 27-33.
Crossref
Crossref
C Kluft & M.P.M de Maat. (2002) Sensitive markers of inflammation make it possible to study the chronic process: the rise of interest in low levels of C-reactive protein. Vascular Pharmacology 39:3, pages 99-104.
Crossref
Crossref
Deepak L. BhattEric J. Topol. (2002) Need to Test the Arterial Inflammation Hypothesis. Circulation 106:1, pages 136-140.
Crossref
Crossref
P Durrington. (2002) THE HUMAN AND ECONOMIC COSTS OF UNDERTREATMENT WITH STATINS. International Journal of Clinical Practice 56:5, pages 357-368.
Crossref
Crossref
Sagar N. Doshi & Jonathan D. Marmur. (2002) Evolving role of tissue factor and its pathway inhibitor. Critical Care Medicine 30:Supplement, pages S241-S250.
Crossref
Crossref
L. Reinares, A. Figueredo, A. Rueda, J.C. Pontes, A. Rodr??guez, M. Ruiz-Yag??e, M.A. Hern??ndez-Presa, C. Pueyo, G. Hern??ndez, A. Fern??ndez-Cruz & R. Pati??o. (2002) Atorvastatin Reduces Expression of the CCR2 and MAC-1 Receptors on Monocytes, and Plasma Levels of Monocyte Chemoattractant Protein-1 and C-Reactive Protein, in Patients with Coronary Heart Disease. Clinical Drug Investigation 22:1, pages 1-8.
Crossref
Crossref
Gerd Schmitz & Michael Torzewski. 2002. HMG-CoA Reductase Inhibitors. HMG-CoA Reductase Inhibitors
55
80
.
Kirsten F. Clemmer, Amy E. Binkoski, Stacie M. Coval, Guixiang Zhao & Penny M. Kris-Etherton. (2001) Diet and drug therapy: A dynamic duo for reducing coronary heart disease risk. Current Atherosclerosis Reports 3:6, pages 507-513.
Crossref
Crossref
Jorge Plutzky. (2001) Inflammatory pathways in atherosclerosis and acute coronary syndromes. The American Journal of Cardiology 88:8, pages 10-15.
Crossref
Crossref
Marc S. PennEric J. Topol. (2001) Tissue Factor, the Emerging Link Between Inflammation, Thrombosis, and Vascular Remodeling. Circulation Research 89:1, pages 1-2.
Crossref
Crossref
John Whicher, Nader Rifai & Luigi M. Biasucci. (2001) Markers of the Acute Phase Response in Cardiovascular Disease: An Update. Clinical Chemistry and Laboratory Medicine 39:11.
Crossref
Crossref